ClinicalTrials.gg
DrugBiological

Collagenase clinical trials

Also written MZ-004.

studies test it
14
open now
0
in phase 3
4
first study started
1995

How each study uses Collagenase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Collagenase
9
Collagenase Santyl
3
collagenase injection
2

Development codes

MZ-004
2

Studies by the year they started

13 studies that test it; most in 2008 (2)

Studies that test Collagenase, by start year
YearStudies
19951
20051
20061
20082
20091
20121
20132
20141
20152
20171

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
6
Phase 3
4
Phase 4
3
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 8

Stony Brook University (3) · State University of New York (2) · Healthpoint (2) · McMaster University (1) · Matrizyme Pharma Corporation (1) · Sunnybrook Health Sciences Centre (1) · Azidus Brasil (1) · University of Kansas Medical Center (1)

Often tested with

Tested in the same studies.

Biological Products (1)

Studies

Open first, then newest update. How each study uses Collagenase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 14